{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:48:32Z","timestamp":1784040512927,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Multisystem inflammatory syndrome in children (MIS-C) has been associated with severe acute respiratory syndrome coronavirus 2 infection in the pediatric population cared for in the pediatric intensive care unit. We aimed to compare patients with pediatric acute respiratory distress syndrome (PARDS) with those who also present a MIS-C diagnosis (PARDS vs. PARDS + MIS-C).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>One hundred and sixty-seven children (0\u201315 years) admitted to the pediatric intensive care unit COVID-19 ward of a national reference children\u2019s hospital in Quito, Ecuador, from June 2020 to June 2021 who developed PARDS with or without MIS-C. To diagnose PARDS, the criteria of the Pediatric Acute Lung Injury Consensus Conference Group were used, and to diagnose MIS-C, the criteria of the Centers for Disease Control and Prevention were used. Additionally, the PRISM score was used to calculate the mortality risk of study patients on admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 167 patients with PARDS, ~59% also developed MIS-C. Patients with PARDS + MIS-C had higher risks than patients without MIS-C in the following: frequency of associated bacterial infections (81.6% vs. 55.1%), mortality risk (36.7% vs. 11.6%), use of respiratory support (invasive mechanical ventilation: 92% vs. 86%), use of vasopressors\/inotropes (90.8% vs. 30.4%), renal complications (36.7% vs. 8.7%), septic shock (84.7% vs. 20.3%), multiorgan failure (39.8% vs. 1.4%) and mortality at discharge (39.8% vs. 4.3%). Logistic regression failed to find an association between MIS-C and age, race, sex, \u22653 signs\/symptoms and \u22652 comorbidities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Patients with PARDS + MIS-C had a more severe clinical picture than patients without MIS-C. The findings provide useful information to improve the management of PARDS patients with and without MIS-C in Ecuador.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003811","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:13:31Z","timestamp":1675372411000},"page":"305-309","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Pediatric Patients With and Without Multisystem Inflammatory Syndrome Associated With COVID-19: Retrospective Cohort From Ecuador"],"prefix":"10.1097","volume":"42","author":[{"given":"Eliana M.","family":"Legarda","sequence":"first","affiliation":[{"name":"Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Quito, Ecuador"},{"name":"Unidad de Cuidados Intensivos Pedi\u00e1tricos, Hospital Pedi\u00e1trico Baca Ortiz, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Unidad de Cuidados Intensivos Pedi\u00e1tricos, Hospital Pedi\u00e1trico Baca Ortiz, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-9044","authenticated-orcid":false,"given":"Ivan","family":"Sisa","sequence":"additional","affiliation":[{"name":"Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Hospital de los Valles, Quito, Ecuador."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"R2-20250614","first-page":"1","article-title":"Multisystem inflammatory syndrome in children (MIS-C) and neonate (MIS-N) associated with COVID-19: optimizing definition and management.","volume":"1","author":"Molloy","year":"2022","journal-title":"Pediatr Res"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/PCC.0000000000002760","article-title":"Coronavirus disease 2019-associated PICU admissions: a report from the society of critical care medicine discovery network viral infection and respiratory illness Universal Study Registry.","volume":"22","author":"Tripathi","year":"2021","journal-title":"Pediatr Crit Care Med"},{"issue":"S1","key":"R4-20250614","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.rcreu.2020.11.004","article-title":"Enfermedad de Kawasaki en Colombia: revisi\u00f3n sistem\u00e1tica y contraste con el s\u00edndrome inflamatorio multisist\u00e9mico en ni\u00f1os asociado a COVID-19.","volume":"29","author":"Llin\u00e1s-Caballero","year":"2022","journal-title":"Revista Colombiana Reumatologia"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"559","DOI":"10.17843\/rpmesp.2020.373.6126","article-title":"S\u00edndrome inflamatorio multisist\u00e9mico asociado a COVID-19 en ni\u00f1os: serie de casos en un hospital pedi\u00e1trico de Per\u00fa.","volume":"37","author":"Coll-Vela","year":"2020","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"646","DOI":"10.32641\/rchped.v91i4.2616","article-title":"S\u00edndrome inflamatorio multisist\u00e9mico asociado con SARS-CoV-2 en pediatr\u00eda.","volume":"91","author":"Bustos","year":"2020","journal-title":"Rev Chil Pediatr"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"116.e1","DOI":"10.1016\/j.anpedi.2020.09.005","article-title":"Documento espa\u00f1ol de consenso sobre diagn\u00f3stico, estabilizaci\u00f3n y tratamiento del s\u00edndrome inflamatorio multisist\u00e9mico pedi\u00e1trico vinculado a SARS- CoV-2 (SIM-PedS).","volume":"94","author":"Garc\u00eda-Salido","year":"2021","journal-title":"An Pediatr (Barc)"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"m3249","DOI":"10.1136\/bmj.m3249","article-title":"Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.","volume":"370","author":"Swann","year":"2020","journal-title":"BMJ"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/PCC.0000000000000350","article-title":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference.","volume":"16","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome.","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PCC.0000000000000558","article-title":"The pediatric risk of mortality score: update 2015.","volume":"17","author":"Pollack","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20250614","first-page":"81","article-title":"Validation of PRISM III (Pediatric Risk of Mortality) scoring system in predicting risk of mortality in a pediatric intensive care unit.","volume":"17","author":"Popli","year":"2018","journal-title":"IOSR J Dent Med Sci"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00296-020-04749-4","article-title":"Severe COVID- 19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.","volume":"41","author":"Kabeerdoss","year":"2021","journal-title":"Rheumatol Int"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"e001295","DOI":"10.1136\/rmdopen-2020-001295","article-title":"Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.","volume":"6","author":"Alunno","year":"2020","journal-title":"RMD open"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMe2023158","article-title":"Childhood multisystem inflammatory syndrome - a new challenge in the pandemic.","volume":"383","author":"Levin","year":"2020","journal-title":"N Engl J Med"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review.","volume":"174","author":"Castagnoli","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12887-021-02743-8","article-title":"COVID- 19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.","volume":"21","author":"Hasan","year":"2021","journal-title":"BMC Pediatr"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jiph.2021.01.008","article-title":"Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: current knowledge and implications for public health.","volume":"14","author":"Rafferty","year":"2021","journal-title":"J Infect Public Health"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"5","DOI":"10.47464\/MetroCiencia\/vol29\/3\/2021\/5-10","article-title":"MIS-C y COVID-19: caracter\u00edsticas cl\u00ednicas y epidemiol\u00f3gicas de los pacientes de una unidad de cuidados cr\u00edticos pedi\u00e1tricos.","volume":"29","author":"Munaico","year":"2021","journal-title":"Metro Ciencia"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:05:13Z","timestamp":1749945913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003811","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,28]]}}}